store at low temperature
store at -80°C
Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 198.00 | |
5 mg | In stock | $ 538.00 | |
10 mg | In stock | $ 863.00 | |
25 mg | In stock | $ 1,290.00 | |
50 mg | In stock | $ 1,760.00 | |
100 mg | In stock | $ 2,380.00 |
Description | Bemarituzumab is a novel humanized IgG1 monoclonal antibody targeting FGFR2b. Bemarituzumab prevents FGFR2b from binding to FGF and activation. Potential applications of Bemarituzumab in cancer research. |
Synonyms | FPA144 |
Molecular Weight | N/A |
CAS No. | 1952272-74-0 |
store at low temperature
store at -80°C
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bemarituzumab 1952272-74-0 Angiogenesis Tyrosine Kinase/Adaptors FGFR FPA144 FPA-144 FPA 144 inhibitor inhibit